Lorena Zapata Cuellar

Mrs. Lorena Zapata Cuellar

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Viral Immunology
Verified
Journal Article
Closed access
EVErendira Villalobos-Sánchez
Erendira Villalobos-Sánchez
MBMirna Burciaga-Flores
Mirna Burciaga-Flores
LCLorena Zapata Cuellar
Lorena Zapata Cuellar
TCTanya A. Camacho-Villegas
Tanya A. Camacho-Villegas
DEDarwin Elizondo-Quiroga
Darwin Elizondo-Quiroga
Zika virus (ZIKV) infections have gained notoriety due to congenital abnormalities. Pregnant women have a greater risk of ZIKV infection and consequent transmission to their progeny due to the immunological changes associated with pregnancy. ZIKV has been detected in amniotic fluid, as well as in fetal and neonatal tissues of infected pregnant women. However, the mechanism by which ZIKV reaches the fetus is not well understood. The four dengue virus serotypes have been the most widely used flaviviruses to elucidate the host–cell entry pathways. Nevertheless, it is of increasing interest to understand the specific interaction between ZIKV and the host cell, especially in the gestation period. Herein, the authors describe the mechanisms of prenatal vertical infection of ZIKV based on results from in vitro, in vivo, and ex vivo studies, including murine models and nonhuman primates. It also includes up-to-date knowledge from ex vivo and natural infections in pregnant women explaining the vertical transmission along four tracks: transplacental, paracellular, transcytosis mediated by extracellular vesicles, and paraplacental route and the antibody-dependent enhancement process. A global understanding of the diverse pathways used by ZIKV to cross the placental barrier and access the fetus, along with a better comprehension of the pathogenesis of ZIKV in pregnant females, may constitute a fundamental role in the design of antiviral drugs to reduce congenital disabilities associated with ZIKV.

30 November 2024 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
AHAna del Socorro Hernández-Aviña
Ana del Socorro Hernández-Aviña
LMLuis Fernando Mendoza-Gómez
Luis Fernando Mendoza-Gómez
XHXitlalli D. Hernández-Mancillas
Xitlalli D. Hernández-Mancillas
JSJorge Alberto Salazar-González
Jorge Alberto Salazar-González
LCLorena Zapata Cuellar
Lorena Zapata Cuellar
Abel Gutiérrez-OrtegaAbel Gutiérrez-Ortega
Abel Gutiérrez-Ortega

23 July 2021 in Molecules
Verified
Journal Article
Open access
PDF file
LCLorena Zapata Cuellar
Lorena Zapata Cuellar
JGJorge Gaona
Jorge Gaona
CMCarlos Alberto Manuel-Cabrera
Carlos Alberto Manuel-Cabrera
Moisés Martínez VelázquezMoisés Martínez Velázquez
Moisés Martínez Velázquez
Carla Sánchez-HernándezCarla Sánchez-Hernández
Carla Sánchez-Hernández
Abel Gutiérrez-OrtegaAbel Gutiérrez-Ortega
Abel Gutiérrez-Ortega
Virus-like particles are excellent inducers of the adaptive immune response of humans and are presently being used as scaffolds for the presentation of foreign peptides and antigens derived from infectious microorganisms for subunit vaccine development. The most common approaches for peptide and antigen presentation are translational fusions and chemical coupling, but some alternatives that seek to simplify the coupling process have been reported recently. In this work, an alternative platform for coupling full antigens to virus-like particles is presented. Heterodimerization motifs inserted in both Tobacco etch virus coat protein and green fluorescent protein directed the coupling process by simple mixing, and the obtained complexes were easily taken up by a macrophage cell line.